Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018Document Transcript
Switzerland Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 73Price: Single User License – US$2500Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, “Switzerland Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018” provides key market data on the Switzerland Diabetes CareDevices market. The report provides value (USD million), volume (units) and average price (USD)data for each segment and sub-segment within two market categories – Glucose Monitoring andInsulin Delivery. The report also provides company shares and distribution shares data for each ofthe aforementioned market categories. The report is supplemented with global corporate-levelprofiles of the key market participants with information on company financials and pipelineproducts, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Switzerland Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., Eli Lilly and Company , Sanofi , NovoNordisk A/S , LifeScan, Inc., Medtronic, Inc.and others.
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Switzerland Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195377-switzerland-diabetes-care-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 62 Introduction 72.1 What is This Report About? 73 Diabetes Care Devices In Switzerland 83.1 Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, 2004-2018 83.2 Diabetes Care Devices, Switzerland, Company Share (2010-2011) 144 Glucose Monitoring In Switzerland 164.1 Glucose Monitoring Overall Revenue, (2004-2018) 164.1.1 Blood Glucose Meters, Revenue (2004-2018) 204.2 Glucose Monitoring Overall Volume (2004-2018) 244.2.1 Blood Glucose Meters, Volume (2004-2018) 284.3 Glucose Monitoring Average Price (2004-2018) 314.4 Glucose Monitoring Distribution Share (2010-2011) 324.5 Glucose Monitoring, Switzerland, Company Share (2010-2011) 335 Insulin Delivery In Switzerland 355.1 Insulin Delivery Overall Revenue, (2004-2018) 355.1.1 Insulin Pens, Revenue (2004-2018) 395.1.2 Insulin Pumps, Revenue (2004-2018) 435.2 Insulin Delivery Overall Volume (2004-2018) 475.2.1 Insulin Pens, Volume (2004-2018) 515.2.2 Insulin Pumps, Volume (2004-2018) 555.3 Insulin Delivery Average Price (2004-2018) 575.4 Insulin Delivery Distribution Share (2010-2011) 58
5.5 Insulin Delivery, Switzerland, Company Share (2010-2011) 596 Overview of Key Companies in Switzerland Diabetes Care Devices Market 616.1 F. Hoffmann-La Roche Ltd. 616.1.1 Company Overview 616.2 Eli Lilly and Company 616.2.1 Company Overview 616.3 Sanofi 626.3.1 Company Overview 626.4 Novo Nordisk A/S 626.4.1 Company Overview 626.5 LifeScan, Inc. 626.5.1 Company Overview 626.6 Medtronic, Inc. 636.6.1 Company Overview 636.7 Bayer HealthCare AG 636.7.1 Company Overview 636.8 Abbott Laboratories 646.8.1 Company Overview 646.9 Animas Corporation 646.9.1 Company Overview 646.10 Becton, Dickinson and Company 656.10.1 Company Overview 656.11 Ypsomed Holding AG 656.11.1 Company Overview 656.12 Terumo Corporation 666.12.1 Company Overview 666.13 Nipro Corporation 666.13.1 Company Overview 667 Appendix 677.1 Global Markets Direct Research Methodology 677.2 Definitions of Markets Covered in the Report 687.2.1 Diabetes Care Devices 687.3 Secondary Research 717.4 Primary Research 717.5 Models 727.6 Forecasts 727.7 Expert Panel Validation 727.8 Currency Conversion 737.9 Contact Us 737.10 Disclaimer 731.1 List of Tables